This metabolite features a PDE selectivity profile comparable to sildenafil and an in vitro potency for PDE5 somewhere around fifty% from the parent drug. Plasma concentrations of the metabolite are around 40% of All those observed for sildenafil, so which the metabolite accounts for around twenty% of sildenafil's pharmacologic results.Sildenafil c